PetMed Express, Inc.

NASDAQ:PETS

4.97 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000
Revenue 281.064256.858273.417309.215284.125283.419273.8249.176234.684229.395233.391227.829238.25231.642238.266219.412188.336162.246137.583108.35893.99454.97532.02610.00614.677
Cost of Revenue 202.416185.844195.341219.267202.879188.105175.993169.862158.388153.125155.774150.708158.085147.686146.405134.085114.12297.6883.24464.755.82431.51818.8946.3689.062
Gross Profit 78.64871.01478.07689.94881.24695.31497.80779.31476.29676.2777.61777.12180.16583.95691.86185.32874.21464.56654.33943.65838.1723.45713.1313.6395.615
Gross Profit Ratio 0.280.2760.2860.2910.2860.3360.3570.3180.3250.3320.3330.3390.3360.3620.3860.3890.3940.3980.3950.4030.4060.4270.410.3640.383
Reseach & Development Expenses 0000000000000000000000000
General & Administrative Expenses 55.24649.47430.82928.29325.26424.76724.2922.79921.30121.10121.35221.59222.36322.222.34121.60520.36717.29314.07811.39610.7547.9576.0944.5077.371
Selling & Marketing Expenses 24.50819.42418.79921.64122.74822.14819.25517.66321.83725.18227.1827.43330.36927.35727.65628.70725.26125.24321.57119.18617.65411.655.7171.3970
SG&A 79.75468.89849.62849.93448.01246.91543.54540.46243.13846.28348.53249.02552.73249.55749.99750.31245.62842.53635.64930.58228.40819.60711.8125.9047.371
Other Expenses 7.0563.5462.7382.4272.2571.0830.9950.30.0630.001-0.004-0.0051.4111.3751.3210.8150.590.530.5450.5740.550.3680.5720.374-0.17
Operating Expenses 86.8172.44452.36652.36150.26949.1445.67141.83143.90846.94349.39950.11654.14350.93251.31951.12746.21843.06636.19431.15628.95819.97412.3836.2787.201
Operating Income -8.162-1.4325.7137.58730.97746.17452.13637.48332.38827.61328.21827.00526.02233.02440.54234.20127.99621.518.14512.5029.2113.4830.748-2.639-1.586
Operating Income Ratio -0.029-0.0060.0940.1220.1090.1630.190.150.1380.120.1210.1190.1090.1430.170.1560.1490.1330.1320.1150.0980.0630.023-0.264-0.108
Total Other Income Expenses Net 1.8890.8941.3611.6292.9162.9471.6530.4410.1790.1850.1810.3010.3490.2530.21.4562.4161.7010.890.1020.002-0.0030.077-0.188-0.014
Income Before Tax -6.2731.58427.07139.21633.89349.12153.78937.92432.56727.79828.39927.30626.37133.27740.74335.65730.41123.20119.03512.6039.2143.480.825-2.827-1.6
Income Before Tax Ratio -0.0220.0060.0990.1270.1190.1730.1960.1520.1390.1210.1220.120.1110.1440.1710.1630.1610.1430.1380.1160.0980.0630.026-0.282-0.109
Income Tax Expense 1.1911.3515.9718.6138.04211.38116.50614.1051210.34510.42710.1419.71212.40614.7412.6810.3898.7576.9724.5933.40.223-0.0770.1880.209
Net Income -7.4640.23318.71623.91925.85137.7437.28323.81920.56717.45317.97217.16516.65920.87126.00222.97620.02214.44412.0648.015.8143.2580.825-2.827-1.794
Net Income Ratio -0.0270.0010.0680.0770.0910.1330.1360.0960.0880.0760.0770.0750.070.090.1090.1050.1060.0890.0880.0740.0620.0590.026-0.282-0.122
EPS -0.370.0121.051.531.291.841.831.181.020.870.90.860.810.931.150.990.830.60.510.350.30.190.05-0.28-0.28
EPS Diluted -0.370.0121.041.521.291.841.821.171.020.870.90.860.80.921.140.980.820.60.50.340.250.160.04-0.28-0.28
EBITDA -1.1062.11628.44840.01433.23448.39954.26238.85233.15830.0429.08528.09627.43334.39941.86335.01628.58622.0318.6913.0759.7623.8511.125-2.265-1.756
EBITDA Ratio -0.0040.0080.1040.1290.1170.1710.1980.1560.1420.1380.1250.1230.1150.1490.1760.1580.1480.1330.1340.1210.1040.070.038-0.225-0.119